Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WDR11-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MKL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
OK/SW-CL.36 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
ATP13A5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCA3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUDT16P1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAMD14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
LOC646482 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASB12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADIG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDK15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MS4A6A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OR51E2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRFIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on